| Year |
Citation |
Score |
| 2014 |
Clarke TK, Crist RC, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH. Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females. The Pharmacogenomics Journal. 14: 303-8. PMID 24126707 DOI: 10.1038/tpj.2013.30 |
0.352 |
|
| 2013 |
Crist RC, Clarke TK, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH. An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2003-10. PMID 23612435 DOI: 10.1038/Npp.2013.99 |
0.461 |
|
| 2013 |
Crist RC, Ambrose-Lanci LM, Zeng A, Yuan C, Kampman KM, Pettinati HM, Oslin DW, O'Brien CP, Ferraro TN, Doyle GA, Lohoff FW, Berrettini WH. Case-control association study of WLS variants in opioid and cocaine addicted populations. Psychiatry Research. 208: 62-6. PMID 23566366 DOI: 10.1016/j.psychres.2013.03.011 |
0.615 |
|
| 2013 |
Crist RC, Ambrose-Lanci LM, Vaswani M, Clarke TK, Zeng A, Yuan C, Ferraro TN, Hakonarson H, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Doyle GA, Lohoff FW, et al. Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations. Drug and Alcohol Dependence. 127: 122-8. PMID 22795689 DOI: 10.1016/J.Drugalcdep.2012.06.023 |
0.64 |
|
| 2013 |
Clarke TK, Bloch PJ, Ambrose-Lanci LM, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Lohoff FW. Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis. Addiction Biology. 18: 702-8. PMID 21790903 DOI: 10.1111/j.1369-1600.2011.00346.x |
0.599 |
|
| 2012 |
Multani PK, Clarke TK, Narasimhan S, Ambrose-Lanci L, Kampman KM, Pettinati HM, Oslin DW, O'Brien CP, Berrettini WH, Lohoff FW. Neuronal calcium sensor-1 and cocaine addiction: a genetic association study in African-Americans and European Americans. Neuroscience Letters. 531: 46-51. PMID 22999924 DOI: 10.1016/j.neulet.2012.09.014 |
0.461 |
|
| 2012 |
Ambrose-Lanci LM, Vaswani M, Clarke TK, Zeng A, Lohoff FW, Ferraro TN, Berrettini WH. Association study of the β-arrestin 2 gene (ARRB2) with opioid and cocaine dependence in a European-American population. Psychiatric Genetics. 22: 141-5. PMID 22472784 DOI: 10.1097/YPG.0b013e3283539528 |
0.605 |
|
| 2012 |
Clarke TK, Ambrose-Lanci L, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Lohoff FW. Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction. Genes, Brain, and Behavior. 11: 415-23. PMID 22443215 DOI: 10.1111/j.1601-183X.2012.00785.x |
0.646 |
|
| 2010 |
Ambrose-Lanci LM, Sterling RC, Van Bockstaele EJ. Cocaine withdrawal-induced anxiety in females: impact of circulating estrogen and potential use of delta-opioid receptor agonists for treatment. Journal of Neuroscience Research. 88: 816-24. PMID 19830839 DOI: 10.1002/Jnr.22259 |
0.54 |
|
| 2009 |
Ambrose-Lanci LM, Sterling RC, Weinstein SP, Van Bockstaele EJ. The influence of intake urinalysis, psychopathology measures, and menstrual cycle phase on treatment compliance. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 18: 167-72. PMID 19283570 DOI: 10.1080/10550490902772710 |
0.304 |
|
| 2008 |
Ambrose-Lanci LM, Peiris NB, Unterwald EM, Van Bockstaele EJ. Cocaine withdrawal-induced trafficking of delta-opioid receptors in rat nucleus accumbens. Brain Research. 1210: 92-102. PMID 18417105 DOI: 10.1016/j.brainres.2008.02.105 |
0.515 |
|
| Show low-probability matches. |